Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study
Raje, Noopur, Terpos, Evangelos, Willenbacher, Wolfgang, Shimizu, Kazuyuki, García-Sanz, Ramón, Durie, Brian, Legieć, Wojciech, Krejčí, Marta, Laribi, Kamel, Zhu, Li, Cheng, Paul, Warner, Douglas, Roodman, G David
Published in The lancet oncology (01.03.2018)
Published in The lancet oncology (01.03.2018)
Get full text
Journal Article
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial
Wei, Andrew H., Montesinos, Pau, Ivanov, Vladimir, DiNardo, Courtney D., Novak, Jan, Laribi, Kamel, Kim, Inho, Stevens, Don A., Fiedler, Walter, Pagoni, Maria, Samoilova, Olga, Hu, Yu, Anagnostopoulos, Achilles, Bergeron, Julie, Hou, Jing-Zhou, Murthy, Vidhya, Yamauchi, Takahiro, McDonald, Andrew, Chyla, Brenda, Gopalakrishnan, Sathej, Jiang, Qi, Mendes, Wellington, Hayslip, John, Panayiotidis, Panayiotis
Published in Blood (11.06.2020)
Published in Blood (11.06.2020)
Get full text
Journal Article
A revised international prognostic score system for Waldenström’s macroglobulinemia
Kastritis, Efstathios, Morel, Pierre, Duhamel, Alain, Gavriatopoulou, Maria, Kyrtsonis, Marie Christine, Durot, Eric, Symeonidis, Argiris, Laribi, Kamel, Hatjiharissi, Evdoxia, Ysebaert, Loic, Vassou, Amalia, Giannakoulas, Nikolaos, Merlini, Giampaolo, Repousis, Panagiotis, Varettoni, Marzia, Michalis, Euridyki, Hivert, Bénédicte, Michail, Michalis, Katodritou, Eirini, Terpos, Evangelos, Leblond, Veronique, Dimopoulos, Meletios A.
Published in Leukemia (01.11.2019)
Published in Leukemia (01.11.2019)
Get full text
Journal Article
Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM
Jakubowiak, Andrzej, Offidani, Massimo, Pégourie, Brigitte, De La Rubia, Javier, Garderet, Laurent, Laribi, Kamel, Bosi, Alberto, Marasca, Roberto, Laubach, Jacob, Mohrbacher, Ann, Carella, Angelo Michele, Singhal, Anil K., Tsao, L.Claire, Lynch, Mark, Bleickardt, Eric, Jou, Ying-Ming, Robbins, Michael, Palumbo, Antonio
Published in Blood (09.06.2016)
Published in Blood (09.06.2016)
Get full text
Journal Article
Bendamustine plus rituximab in newly‐diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO)
Laribi, Kamel, Poulain, Stéphanie, Willems, Lise, Merabet, Fatiha, Le Calloch, Ronan, Eveillard, Jean R., Herbaux, Charles, Roos‐Weil, Damien, Chaoui, Driss, Roussel, Xavier, Tricot, Sabine, Dupuis, Jehan, Dartigeas, Caroline, Bareau, Benoit, Bene, Marie C., Baugier de Materre, Alix, Leblond, Véronique
Published in British journal of haematology (01.07.2019)
Published in British journal of haematology (01.07.2019)
Get full text
Journal Article
Response to vaccination against SARS‐CoV‐2 in 168 patients with Waldenström macroglobulinaemia: A French Innovative Leukaemia Organization study
Tomowiak, Cécile, Leblond, Véronique, Laribi, Kamel, Baron, Marine, Puppinck, Christian, Gérard, Paulette, Courret, Elodie, Gorochov, Guy, Sterlin, Delphine, Tournilhac, Olivier, Morel, Pierre, Cymbalista, Florence, Roos‐Weil, Damien
Published in British journal of haematology (01.05.2022)
Published in British journal of haematology (01.05.2022)
Get full text
Journal Article
Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study
Michallet, Anne-Sophie, Aktan, Melih, Hiddemann, Wolfgang, Ilhan, Osman, Johansson, Peter, Laribi, Kamel, Meddeb, Balkis, Moreno, Carol, Raposo, João, Schuh, Anna, Ünal, Ali, Widenius, Tom, Bernhardt, Alf, Kellershohn, Kerstin, Messeri, Dimitri, Osborne, Stuart, Leblond, Véronique
Published in Haematologica (Roma) (01.04.2018)
Published in Haematologica (Roma) (01.04.2018)
Get full text
Journal Article
Long-term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO)
Laribi, Kamel, Poulain, Stéphanie, Willems, Lise, Merabet, Fatiha, Herbaux, Charles, Roos-Weil, Damien, Laribi de Materre, Inès, Roussel, Xavier, Nudel, Morgane, Tricot, Sabine, Dupuis, Jehan, Le Calloch, Ronan, Bareau, Benoit, Leblond, Véronique
Published in British journal of haematology (01.06.2024)
Published in British journal of haematology (01.06.2024)
Get full text
Journal Article
IgM k multiple myeloma with monoclonal surface immunoglobulin expression
Laribi, Kamel, Alani, Mustafa, Lemaire, Pierre
Published in International journal of hematology (01.07.2018)
Published in International journal of hematology (01.07.2018)
Get full text
Journal Article
Response to vaccination against SARS-CoV-2 in 168 patients with Waldenström macroglobulinemia: a French Innovative Leukemia Organization (FILO) study
Tomowiak, Cécile, Leblond, Véronique, Laribi, Kamel, Baron, Marine, Puppinck, Christian, Gérard, Paulette, Courret, Elodie, Gorochov, Guy, Sterlin, Delphine, Tournilhac, Olivier, Morel, Pierre, Cymbalista, Florence, Roos-Weil, Damien
Published in British journal of haematology (14.01.2022)
Published in British journal of haematology (14.01.2022)
Get full text
Journal Article
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial
Braun, Thorsten, Itzykson, Raphael, Renneville, Aline, de Renzis, Benoit, Dreyfus, François, Laribi, Kamel, Bouabdallah, Krimo, Vey, Norbert, Toma, Andrea, Recher, Christian, Royer, Bruno, Joly, Bertrand, Vekhoff, Anne, Lafon, Ingrid, Sanhes, Laurence, Meurice, Guillaume, Oréar, Cédric, Preudhomme, Claude, Gardin, Claude, Ades, Lionel, Fontenay, Michaela, Fenaux, Pierre, Droin, Nathalie, Solary, Eric
Published in Blood (06.10.2011)
Published in Blood (06.10.2011)
Get full text
Journal Article
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher‐Risk MDS or low blast AML: GFM's “pick a winner” trial, with the impact of somatic mutations
Adès, Lionel, Duployez, Nicolas, Guerci‐Bresler, Agnes, Laribi, Kamel, Peterlin, Pierre, Vey, Norbert, Thepot, Sylvain, Wickenhauser, Stefan, Zerazhi, Hacene, Stamatoullas, Aspassia, Wattel, Eric, Recher, Christian, Toma, Andrea, Dimicoli‐Salazar, Sophie, Braun, Thorsten, Beyne‐Rauzy, Odile, Marolleau, Jean‐Pierre, Cheze, Stéphane, Park, Sophie, Cluzeau, Thomas, Nimubona, Stanislas, Bordessoule, Dominique, Benramdane, Riad, Quesnel, Bruno, Amé, Shanti, Botton, Stéphane, Chermat, Fathia, Preudhomme, Claude, Chevret, Sylvie, Fenaux, Pierre
Published in British journal of haematology (01.08.2022)
Published in British journal of haematology (01.08.2022)
Get full text
Journal Article
A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure
Sébert, Marie, Renneville, Aline, Bally, Cécile, Peterlin, Pierre, Beyne-Rauzy, Odile, Legros, Laurence, Gourin, Marie-Pierre, Sanhes, Laurence, Wattel, Eric, Gyan, Emmanuel, Park, Sophie, Stamatoullas, Aspasia, Banos, Anne, Laribi, Kamel, Jueliger, Simone, Bevan, Luke, Chermat, Fatiha, Sapena, Rosa, Nibourel, Olivier, Chaffaut, Cendrine, Chevret, Sylvie, Preudhomme, Claude, Adès, Lionel, Fenaux, Pierre
Published in Haematologica (Roma) (01.08.2019)
Published in Haematologica (Roma) (01.08.2019)
Get full text
Journal Article
6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy
Wei, Andrew H., Panayiotidis, Panayiotis, Montesinos, Pau, Laribi, Kamel, Ivanov, Vladimir, Kim, Inho, Novak, Jan, Stevens, Don A., Fiedler, Walter, Pagoni, Maria, Bergeron, Julie, Ting, Stephen B., Hou, Jing-Zhou, Anagnostopoulos, Achilles, McDonald, Andrew, Murthy, Vidhya, Yamauchi, Takahiro, Wang, Jianxiang, Chyla, Brenda, Sun, Yan, Jiang, Qi, Mendes, Wellington, Hayslip, John, DiNardo, Courtney D.
Published in Blood cancer journal (New York) (01.10.2021)
Published in Blood cancer journal (New York) (01.10.2021)
Get full text
Journal Article
Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study
Ianotto, Jean-Christophe, Chauveau, Aurélie, Boyer-Perrard, Françoise, Gyan, Emmanuel, Laribi, Kamel, Cony-Makhoul, Pascale, Demory, Jean-Loup, de Renzis, Benoit, Dosquet, Christine, Rey, Jerome, Roy, Lydia, Dupriez, Brigitte, Knoops, Laurent, Legros, Laurence, Malou, Mohamed, Hutin, Pascal, Ranta, Dana, Benbrahim, Omar, Ugo, Valérie, Lippert, Eric, Kiladjian, Jean-Jacques
Published in Haematologica (Roma) (01.03.2018)
Published in Haematologica (Roma) (01.03.2018)
Get full text
Journal Article
Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial
Guièze, Romain, Ysebaert, Loïc, Roos-Weil, Damien, Fornecker, Luc-Mathieu, Ferrant, Emmanuelle, Molina, Lysiane, Aurran, Thérèse, Clavert, Aline, de Guibert, Sophie, Michallet, Anne-Sophie, Saad, Alain, Drénou, Bernard, Quittet, Philippe, Hivert, Bénédicte, Laribi, Kamel, Gay, Julie, Quinquenel, Anne, Broseus, Julien, Rouille, Valérie, Schwartz, David, Magnin, Benoit, Lazarian, Grégory, Véronèse, Lauren, de Antonio, Marie, Laurent, Camille, Tournilhac, Olivier, Pereira, Bruno, Feugier, Pierre
Published in Nature communications (09.08.2024)
Published in Nature communications (09.08.2024)
Get full text
Journal Article
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: IFM 2020-04 study
Talbot, Alexis, Bobin, Arthur, Tabone, Léa, Lambert, Jérôme, Boccaccio, Catherine, Deal, Cécile, Petillon, Marie-Odile, Allangba, Olivier, Agape, Philippe, Arnautou, Pierre, Belkhir, Rakiba, Cailleres, Sylvie, Chaoui, Driss, Chrétien, Marie-Lorraine, Decaux, Olivier, Schulmann, Samantha, Frenzel, Laurent, Gastaud, Lauris, Huart, Antoine, Hulin, Cyrille, Karlin, Lionel, Laribi, Kamel, Le Calloch, Ronan, Lenain, Pascal, Macro, Margaret, Manier, Salomon, Montes, Lydia, Moreau, Stéphane, Moreau, Philippe, Morel, Véronique, Norwood, James, Piocelle, Frédérique Orsini, Perrot, Aurore, Pica, Gian Matteo, Rey, Philippe, Schmitt, Anna, Stoppa, Anne-Marie, Tiab, Mourad, Touzeau, Cyrille, Vidal, Valérie, Vignon, Marguerite, Vincent, Laure, Van De Wyngaert, Zoé, Zarnitsky, Charles, Kerbouche, Naima, Paka, Prani, Leleu, Xavier, Arnulf, Bertrand, Avet-Loiseau, Hervé
Published in Haematologica (Roma) (01.10.2023)
Published in Haematologica (Roma) (01.10.2023)
Get full text
Journal Article
Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real‐life study
Comont, Thibault, Meunier, Mathieu, Cherait, Amina, Santana, Clemence, Cluzeau, Thomas, Slama, Bohrane, Laribi, Kamel, Giraud, Jean‐Thomas, Dimicoli, Sophie, Berceanu, Ana, Le Clech, Lenaïg, Cony‐Makhoul, Pascale, Gruson, Berangere, Torregrosa, Jose, Sanhes, Laurence, Jachiet, Vincent, Azerad, Marie‐Agnes, Al Jijakli, Ahmad, Gyan, Emmanuel, Gaudin, Clement, Broner, Jonathan, Guerveno, Claire, Guillaume, Thierry, Ades, Pr Lionel, Beyne‐Rauzy, Odile, Fenaux, Pierre
Published in British journal of haematology (01.07.2021)
Published in British journal of haematology (01.07.2021)
Get full text
Journal Article
Web Resource
Filgrastim prophylaxis in elderly cancer patients in the real-life setting: a French multicenter observational study, the TULIP study
Laribi, Kamel, Badinand, Delphine, Janoray, Philippe, Benabed, Khaled, Mouysset, Jean-Loup, Fabre, Elizabeth, Monchecourt, Françoise, Diab, Rafik
Published in Supportive care in cancer (01.11.2019)
Published in Supportive care in cancer (01.11.2019)
Get full text
Journal Article